Pub. Date : 2021
PMID : 34421608
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways. | Metformin | protein kinase AMP-activated non-catalytic subunit beta 1 | Homo sapiens |
| 2 | Interesting, metformin also exerts broad anticancer effects through the activation of AMP-activated protein kinase (AMPK) and inhibition of mammalian target of rapamycin (mTOR). | Metformin | protein kinase AMP-activated non-catalytic subunit beta 1 | Homo sapiens |
| 3 | Interesting, metformin also exerts broad anticancer effects through the activation of AMP-activated protein kinase (AMPK) and inhibition of mammalian target of rapamycin (mTOR). | Metformin | protein kinase AMP-activated non-catalytic subunit beta 1 | Homo sapiens |
| 4 | Moreover, anlotinib combined with metformin induced apoptosis and oxidative stress, which was associated with the activation of AMPK and inhibition of mTOR. | Metformin | protein kinase AMP-activated non-catalytic subunit beta 1 | Homo sapiens |